Real-time enrollment status for this chronic kidney disease clinical trial
Current Status
Recruiting
Checked: October 24, 2026 at 10:55 PM UTC
| NCT Number | NCT07753993 |
| Recruiting Status | Recruiting |
| Condition | Chronic Kidney Disease |
| Phase | PHASE3 |
| Target Enrollment | 7,000 participants |
| Active Locations | 120 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 9, 2026 (Sep 9, 2026) |
As of October 24, 2026: Clinical trial NCT07753993 is currently recruiting participants. This phase3 study for chronic kidney disease is actively seeking new participants at 120 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07753993 is actively recruiting participants as of October 24, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 120 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07753993 was last updated Sep 9, 2026 (September 9, 2026). HelloStudys verifies this status automatically.